Related Experiment Video
Updated: Jul 16, 2026
10:31
An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
[Metabolic syndrome in childhood]
1Departamento de Pediatría, Hospital Costa del Sol, Marbella, España. leotapiaceb@hotmail.com
Anales De Pediatria (Barcelona, Spain : 2003)
|February 20, 2007
Summary
Childhood obesity is a growing public health concern, increasing adult risks for metabolic syndrome and cardiovascular disease. Early identification and intervention are crucial for long-term health outcomes.
Area of Science:
- Pediatric Endocrinology
- Public Health
- Metabolic Disorders
Background:
- Obesity is a global epidemic, recognized as a major public health challenge by the World Health Organization.
- The enKid study in Spain reported high prevalences of obesity (13.9%) and overweight (12.4%) in individuals aged 2-24 years.
- Childhood obesity is linked to increased risks of adult obesity, morbidity, and mortality from persistent metabolic disorders.
Purpose of the Study:
- To highlight the public health significance of childhood obesity.
- To discuss the association between childhood obesity and metabolic syndrome.
- To underscore the lack of a universal definition for pediatric metabolic syndrome.
Main Methods:
- Review of existing literature on childhood obesity and metabolic syndrome.
- Analysis of data from the enKid study in Spain.
- Discussion of the pathophysiology of metabolic syndrome, emphasizing insulin resistance.
Main Results:
- Childhood obesity predicts adult obesity and associated health risks.
- Metabolic syndrome, characterized by multiple risk factors, is a significant concern in obese pediatric patients.
- Prevalence of metabolic syndrome in obese children ranges from 20-30%, despite no universally accepted pediatric definition.
Conclusions:
- Childhood obesity poses a substantial risk for developing metabolic syndrome and related adult diseases.
- The absence of a standardized pediatric definition for metabolic syndrome impedes accurate prevalence assessment and management.
- Further research and consensus are needed for defining and managing pediatric metabolic syndrome effectively.
More Related Videos
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...